Evaluation of outcome and prognostic factors for dogs living greater than one year after diagnosis of osteosarcoma: 90 Cases (1997-2008)

William T Culp, Francisco Olea-Popelka, Jennifer Sefton, Charles F. Aldridge, Stephen J. Withrow, Mary H. Lafferty, Robert B Rebhun, Michael S Kent, Nicole Ehrhart

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Objective: To evaluate clinical characteristics, outcome, and prognostic variables in a cohort of dogs surviving > 1 year after an initial diagnosis of osteosarcoma.

Design: Retrospective case series.

Animals: 90 client-owned dogs.

Procedures: Medical records for an 11-year period from 1997 through 2008 were reviewed, and patients with appendicular osteosarcoma that lived > 1 year after initial histopathologic diagnosis were studied. Variables including signalment, weight, serum alkaline phosphatase activity, tumor location, surgery, and adjuvant therapies were recorded. Median survival times were calculated by means of a Kaplan-Meier survival function. Univariate analysis was conducted to compare the survival function for categorical variables, and the Cox proportional hazard model was used to evaluate the likelihood of death > 1 year after diagnosis on the basis of the selected risk factors.

Results: 90 dogs met the inclusion criteria; clinical laboratory information was not available in all cases. Median age was 8.2 years (range, 2.7 to 13.3 years), and median weight was 38 kg (83.6 lb; range, 21 to 80 kg [46.2 to 176 lb]). Serum alkaline phosphatase activity was high in 29 of 60 (48%) dogs. The most common tumor location was the distal portion of the radius (54/90 [60%]). Eighty-nine of 90 (99%) dogs underwent surgery, and 78 (87%) received chemotherapy. Overall, 49 of 90 (54%) dogs developed metastatic disease. The median survival time beyond 1 year was 243 days (range, 1 to 1,899 days). Dogs that developed a surgical-site infection after limb-sparing surgery had a significantly improved prognosis > 1 year after osteosarcoma diagnosis, compared with dogs that did not develop infections.

Conclusions and Clinical Relevance: Results of the present study indicated that dogs with an initial diagnosis of osteosarcoma that lived > 1 year had a median survival time beyond the initial year of approximately 8 months. As reported previously, the development of a surgical-site infection in dogs undergoing a limb-sparing surgery significantly affected prognosis and warrants further study.

Original languageEnglish (US)
Pages (from-to)1141-1146
Number of pages6
JournalJournal of the American Veterinary Medical Association
Volume245
Issue number10
StatePublished - Nov 15 2014

Fingerprint

osteosarcoma
Osteosarcoma
Dogs
dogs
surgery
Surgical Wound Infection
Survival
limbs (animal)
prognosis
Alkaline Phosphatase
alkaline phosphatase
Extremities
infection
Weights and Measures
neoplasms
Serum
Proportional Hazards Models
drug therapy
adjuvants
Medical Records

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Evaluation of outcome and prognostic factors for dogs living greater than one year after diagnosis of osteosarcoma : 90 Cases (1997-2008). / Culp, William T; Olea-Popelka, Francisco; Sefton, Jennifer; Aldridge, Charles F.; Withrow, Stephen J.; Lafferty, Mary H.; Rebhun, Robert B; Kent, Michael S; Ehrhart, Nicole.

In: Journal of the American Veterinary Medical Association, Vol. 245, No. 10, 15.11.2014, p. 1141-1146.

Research output: Contribution to journalArticle

Culp, William T ; Olea-Popelka, Francisco ; Sefton, Jennifer ; Aldridge, Charles F. ; Withrow, Stephen J. ; Lafferty, Mary H. ; Rebhun, Robert B ; Kent, Michael S ; Ehrhart, Nicole. / Evaluation of outcome and prognostic factors for dogs living greater than one year after diagnosis of osteosarcoma : 90 Cases (1997-2008). In: Journal of the American Veterinary Medical Association. 2014 ; Vol. 245, No. 10. pp. 1141-1146.
@article{bee3b2be50bf4b1cb9681816757cc052,
title = "Evaluation of outcome and prognostic factors for dogs living greater than one year after diagnosis of osteosarcoma: 90 Cases (1997-2008)",
abstract = "Objective: To evaluate clinical characteristics, outcome, and prognostic variables in a cohort of dogs surviving > 1 year after an initial diagnosis of osteosarcoma.Design: Retrospective case series.Animals: 90 client-owned dogs.Procedures: Medical records for an 11-year period from 1997 through 2008 were reviewed, and patients with appendicular osteosarcoma that lived > 1 year after initial histopathologic diagnosis were studied. Variables including signalment, weight, serum alkaline phosphatase activity, tumor location, surgery, and adjuvant therapies were recorded. Median survival times were calculated by means of a Kaplan-Meier survival function. Univariate analysis was conducted to compare the survival function for categorical variables, and the Cox proportional hazard model was used to evaluate the likelihood of death > 1 year after diagnosis on the basis of the selected risk factors.Results: 90 dogs met the inclusion criteria; clinical laboratory information was not available in all cases. Median age was 8.2 years (range, 2.7 to 13.3 years), and median weight was 38 kg (83.6 lb; range, 21 to 80 kg [46.2 to 176 lb]). Serum alkaline phosphatase activity was high in 29 of 60 (48{\%}) dogs. The most common tumor location was the distal portion of the radius (54/90 [60{\%}]). Eighty-nine of 90 (99{\%}) dogs underwent surgery, and 78 (87{\%}) received chemotherapy. Overall, 49 of 90 (54{\%}) dogs developed metastatic disease. The median survival time beyond 1 year was 243 days (range, 1 to 1,899 days). Dogs that developed a surgical-site infection after limb-sparing surgery had a significantly improved prognosis > 1 year after osteosarcoma diagnosis, compared with dogs that did not develop infections.Conclusions and Clinical Relevance: Results of the present study indicated that dogs with an initial diagnosis of osteosarcoma that lived > 1 year had a median survival time beyond the initial year of approximately 8 months. As reported previously, the development of a surgical-site infection in dogs undergoing a limb-sparing surgery significantly affected prognosis and warrants further study.",
author = "Culp, {William T} and Francisco Olea-Popelka and Jennifer Sefton and Aldridge, {Charles F.} and Withrow, {Stephen J.} and Lafferty, {Mary H.} and Rebhun, {Robert B} and Kent, {Michael S} and Nicole Ehrhart",
year = "2014",
month = "11",
day = "15",
language = "English (US)",
volume = "245",
pages = "1141--1146",
journal = "Journal of the American Veterinary Medical Association",
issn = "0003-1488",
publisher = "American Veterinary Medical Association",
number = "10",

}

TY - JOUR

T1 - Evaluation of outcome and prognostic factors for dogs living greater than one year after diagnosis of osteosarcoma

T2 - 90 Cases (1997-2008)

AU - Culp, William T

AU - Olea-Popelka, Francisco

AU - Sefton, Jennifer

AU - Aldridge, Charles F.

AU - Withrow, Stephen J.

AU - Lafferty, Mary H.

AU - Rebhun, Robert B

AU - Kent, Michael S

AU - Ehrhart, Nicole

PY - 2014/11/15

Y1 - 2014/11/15

N2 - Objective: To evaluate clinical characteristics, outcome, and prognostic variables in a cohort of dogs surviving > 1 year after an initial diagnosis of osteosarcoma.Design: Retrospective case series.Animals: 90 client-owned dogs.Procedures: Medical records for an 11-year period from 1997 through 2008 were reviewed, and patients with appendicular osteosarcoma that lived > 1 year after initial histopathologic diagnosis were studied. Variables including signalment, weight, serum alkaline phosphatase activity, tumor location, surgery, and adjuvant therapies were recorded. Median survival times were calculated by means of a Kaplan-Meier survival function. Univariate analysis was conducted to compare the survival function for categorical variables, and the Cox proportional hazard model was used to evaluate the likelihood of death > 1 year after diagnosis on the basis of the selected risk factors.Results: 90 dogs met the inclusion criteria; clinical laboratory information was not available in all cases. Median age was 8.2 years (range, 2.7 to 13.3 years), and median weight was 38 kg (83.6 lb; range, 21 to 80 kg [46.2 to 176 lb]). Serum alkaline phosphatase activity was high in 29 of 60 (48%) dogs. The most common tumor location was the distal portion of the radius (54/90 [60%]). Eighty-nine of 90 (99%) dogs underwent surgery, and 78 (87%) received chemotherapy. Overall, 49 of 90 (54%) dogs developed metastatic disease. The median survival time beyond 1 year was 243 days (range, 1 to 1,899 days). Dogs that developed a surgical-site infection after limb-sparing surgery had a significantly improved prognosis > 1 year after osteosarcoma diagnosis, compared with dogs that did not develop infections.Conclusions and Clinical Relevance: Results of the present study indicated that dogs with an initial diagnosis of osteosarcoma that lived > 1 year had a median survival time beyond the initial year of approximately 8 months. As reported previously, the development of a surgical-site infection in dogs undergoing a limb-sparing surgery significantly affected prognosis and warrants further study.

AB - Objective: To evaluate clinical characteristics, outcome, and prognostic variables in a cohort of dogs surviving > 1 year after an initial diagnosis of osteosarcoma.Design: Retrospective case series.Animals: 90 client-owned dogs.Procedures: Medical records for an 11-year period from 1997 through 2008 were reviewed, and patients with appendicular osteosarcoma that lived > 1 year after initial histopathologic diagnosis were studied. Variables including signalment, weight, serum alkaline phosphatase activity, tumor location, surgery, and adjuvant therapies were recorded. Median survival times were calculated by means of a Kaplan-Meier survival function. Univariate analysis was conducted to compare the survival function for categorical variables, and the Cox proportional hazard model was used to evaluate the likelihood of death > 1 year after diagnosis on the basis of the selected risk factors.Results: 90 dogs met the inclusion criteria; clinical laboratory information was not available in all cases. Median age was 8.2 years (range, 2.7 to 13.3 years), and median weight was 38 kg (83.6 lb; range, 21 to 80 kg [46.2 to 176 lb]). Serum alkaline phosphatase activity was high in 29 of 60 (48%) dogs. The most common tumor location was the distal portion of the radius (54/90 [60%]). Eighty-nine of 90 (99%) dogs underwent surgery, and 78 (87%) received chemotherapy. Overall, 49 of 90 (54%) dogs developed metastatic disease. The median survival time beyond 1 year was 243 days (range, 1 to 1,899 days). Dogs that developed a surgical-site infection after limb-sparing surgery had a significantly improved prognosis > 1 year after osteosarcoma diagnosis, compared with dogs that did not develop infections.Conclusions and Clinical Relevance: Results of the present study indicated that dogs with an initial diagnosis of osteosarcoma that lived > 1 year had a median survival time beyond the initial year of approximately 8 months. As reported previously, the development of a surgical-site infection in dogs undergoing a limb-sparing surgery significantly affected prognosis and warrants further study.

UR - http://www.scopus.com/inward/record.url?scp=84908338112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908338112&partnerID=8YFLogxK

M3 - Article

C2 - 25356715

AN - SCOPUS:84908338112

VL - 245

SP - 1141

EP - 1146

JO - Journal of the American Veterinary Medical Association

JF - Journal of the American Veterinary Medical Association

SN - 0003-1488

IS - 10

ER -